These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23480563)

  • 21. Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.
    Zhuo J; Fu W; Liu S
    Ultraschall Med; 2014 Oct; 35(5):468-72. PubMed ID: 24327471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.
    Cross CK; Berman S; Buswell L; Johnson B; Baldini EH
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1098-105. PubMed ID: 15001250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Song C; Hong BJ; Bok S; Lee CJ; Kim YE; Jeon SR; Wu HG; Lee YS; Cheon GJ; Paeng JC; Carlson DJ; Kim HJ; Ahn GO
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1022-1031. PubMed ID: 27130790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
    Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
    Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
    Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
    Sonveaux P; Brouet A; Havaux X; Grégoire V; Dessy C; Balligand JL; Feron O
    Cancer Res; 2003 Mar; 63(5):1012-9. PubMed ID: 12615716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of local carbon ion irradiation on survival and peripheral blood leukocyte and platelet counts of tumor-bearing mice].
    Ding XF; Chen LH; Li WJ; Li DX
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1432-4. PubMed ID: 16305974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer.
    Lee JH; Wu HG; Kim HJ; Park CI; Lee SH; Kim DW; Heo DS
    Radiat Oncol J; 2013 Mar; 31(1):18-24. PubMed ID: 23620865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
    Pemberton LS; Din OS; Fisher PM; Hatton MQ
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy.
    Gay HA; Sibata CH; Allison RR; Jeremic B
    Radiother Oncol; 2009 Jun; 91(3):369-78. PubMed ID: 19058867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
    Dirkx ML; van Sörnsen De Koste JR; Senan S
    Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
    Miralbell R; Mollà M; Rouzaud M; Hidalgo A; Toscas JI; Lozano J; Sanz S; Ares C; Jorcano S; Linero D; Escudé L
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):50-7. PubMed ID: 19910135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
    Qiu M; Yi C; Hou M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):534-7. PubMed ID: 16909595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules.
    Kim DW; Huamani J; Niermann KJ; Lee H; Geng L; Leavitt LL; Baheza RA; Jones CC; Tumkur S; Yankeelov TE; Fleischer AC; Hallahan DE
    J Ultrasound Med; 2006 Dec; 25(12):1507-17. PubMed ID: 17121945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low- dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer.
    Jiang S; Zhou Y; Zou L; Chu L; Chu X; Ni J; Li Y; Guo T; Yang X; Zhu Z
    Cancer Med; 2023 Feb; 12(4):4434-4445. PubMed ID: 36065943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.